Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9236568 | Clinical Immunology | 2005 | 13 Pages |
Abstract
Lupus patients selectively produce autoantibodies against nucleoproteins. Since the RNA/DNA components of these autoantigens are endogenous TLR ligands capable of stimulating Type I interferon (IFN-I) production, we asked whether autoantibodies against the ribonucleoproteins Sm/RNP and Ro60 and double-stranded DNA are associated with high levels of IFN-I. IFN-I levels were increased in SLE (n = 88) vs. other autoimmune diseases (n = 82) and controls (n = 57) (P < 0.0001) and were associated positively with autoantibodies against Sm/RNP, Ro60/La, and dsDNA but negatively with anti-phospholipid. Low numbers of circulating plasmacytoid and myeloid dendritic cells also were associated with these autoantibodies. The IFN-I and dendritic cell abnormalities correlated with disease severity and were not therapy-related. These findings suggest that immunostimulatory nucleic acid components of autoantigens may act as endogenous adjuvants by promoting IFN-I production and dendritic cell maturation, helping to explain the high prevalence of autoantibodies against nucleoprotein antigens in SLE.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Haoyang Zhuang, Sonali Narain, Eric Sobel, Pui Y. Lee, Dina C. Nacionales, Kindra M. Kelly, Hanno B. Richards, Mark Segal, Carol Stewart, Minoru Satoh, Westley H. Reeves,